Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Beattie; David
Address:
Horsham, GB
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8283362 Beta-2-adrenoreceptor agonists October 9, 2012
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
8273900 Organic compounds September 25, 2012
There are described cyclohexyl amide derivatives useful as corticotropin releasing factor (CRF.sub.1) receptor antagonists.
8067437 Beta-2-adrenoreceptor agonists November 29, 2011
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7820694 Beta-2-adrenoreceptor agonists October 26, 2010
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7745462 Quinoline-2-one derivatives for the treatment of airways diseases June 29, 2010
Compounds of formula I ##STR00001## in free or salt form, wherein --C--Y--, R.sup.1 and R.sup.2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the .beta..sub.2-adrenoreceptor. Pharmaceut
7622483 .beta.2-adrenoceptor agonists November 24, 2009
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
6921757 Organic compounds July 26, 2005
Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals ##STR1##
6878721 Beta2-adrenoceptor agonists April 12, 2005
Compounds of formula ##STR1##in free or salt or solvate form, where Ar is a group of formula ##STR2##Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their p










 
 
  Recently Added Patents
Pointer display device, pointer display/detection method, pointer display/detection program and information apparatus
Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof
Point-in-time copies in a cascade using maps and fdisks
Low cost mesh network capability
Solid-state imaging apparatus
Image sorting device, method, program, and integrated circuit and storage medium storing said program
Keyswitch controller
  Randomly Featured Patents
Sterilizing and desorbing equipment
Semiconductor package adapted for high-speed data processing and damage prevention of chips packaged therein and method for fabricating the same
Constant tensioning device
Nitrogen-containing heterocyclic compounds and methods of use thereof
Miniature electrical ball and tube socket assembly with self-capturing multiple-contact-point coupling
Electrically conductive glasslike films on glass or ceramic surfaces from aluminum and plumbite-treated cellulosics
Porous glass preform production apparatus
Method and apparatus of combustion for a pipestill heater
Cathode ray tube having shadow mask
Ink composition, ink for inkjet recording and ink set using the ink